Table 2 Background characteristics of the respondents
Study 1 (n = 157) | Study 2 (n = 104) | |
|---|---|---|
Frequencies (%) | Frequencies (%) | |
Men | 66 (42) | 39 (38) |
Women | 91 (58) | 65 (62) |
Age mean (SDa) | 50 (15) | 49 (14) |
Asthma inhalers | ||
Corticosteroids | 64 (41) | 38 (36) |
Combination therapy (corticosteroids + long-acting beta2-agonists) | 40 (25) | 30 (29) |
Short-acting beta2-agonists | 84 (53) | 64 (61) |
Long-acting beta2-agonists | 17 (10) | 10 (9) |